← Leaderboards
Bruce A Barshop
University Of California San Diego
$109,215
Attributed
$109,215
Total exposure
19
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $31.1K · FY2005–10$50K$37.5K$25K$12.5K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$109,215 · 19
By mechanism
M01$109,215 · 19
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Jerry A Schneider$14,686
- Joel Edward Lavine$18,648,424
- Jane C Burns$14,170,537
- Doris A Trauner$6,463,819
- Ranjan Dohil$332,422
Research focus
Computer Retrieval Of Information On Scientific Projects DatabaseResearch PersonnelUnited States National Institutes Of HealthSourceResourcesFundingInstitutionGrantSafetyClinical TrialsClinical ResearchGlycogen Storage Disease Type IiQuality Of LifePyrimidinesCognitive FunctionSigns And SymptomsNeurologic DysfunctionsSeizuresLanguagePyrimidinePn401 (Triacetyluridine)PredispositionInfectionSpeech
Grant awards (46)
CYSTEAMINE BITARTRATE DELAYED-RELESEASE CAPSULES (RP103) COMPARED TO CYSTEAMINE$19,502
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: ALGLUCOSIDASE ALFA TEMPORARY ACCESS PROGRAM (ATAP) PROTOCOL AGLU$11,045
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUR$518
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: MYOZYME? TEMPORARY ACCESS PROGRAM (MTAP)$16,985
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: EXTENSION STUDY - LATE ONSET POMPE DISEASE$6,794
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUR$1,133
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: MYOZYME TREATMENT IN PATIENTS WITH LATE ONSET POMPE DISEASE$10,991
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: EXTENSION STUDY - LATE ONSET POMPE DISEASE$8,243
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUR$1,374
M01 · FY2008 · RR · contact PI
MYOZYME TREATMENT IN PATIENTS WITH LATE ONSET POMPE DISEASE$2,713
M01 · FY2007 · RR · contact PI
A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUROLOGICAL DYSF$1,938
M01 · FY2007 · RR · contact PI
PHASE II OPEN TRIAL OF DICHLOROACETATE IN CONGENITAL LACTIC ACIDEMIA$2,628
M01 · FY2006 · RR · contact PI
A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUROLOGICAL DYSF$2,628
M01 · FY2006 · RR · contact PI
LEUCINE METABOLISM AND LIVER TRANSPLANTATION$1,577
M01 · FY2006 · RR · contact PI
LEUCINE METABOLISM AND LIVER TRANSPLANTATION$8,548
M01 · FY2005 · RR
PHASE II OPEN TRIAL OF DICHLOROACETATE IN CONGENITAL LACTIC ACIDEMIA$2,442
M01 · FY2005 · RR
PN401 IN PATIENTS WITH PYRIMIDINE RESPONSIVE SYNDROME$2,442
M01 · FY2005 · RR
DICHLOROACETATE IN THE TREATMENT OF CONGENITAL LACTIC ACIDEMIA$1,222
M01 · FY2005 · RR
Pn401 In Patients with Pyrimidine Responsive Syndrome$3,541
M01 · FY2004 · RR
Dichloroacetate in Congenital Lacic Acidemia$2,951
M01 · FY2004 · RR
TOLERANCE EVALUATION OF FRUCTO-OLIGOSACCHARIDES IN FRUCTOSE INTOLERANCE$0
M01 · FY2002 · RR
BLOOD SAMPLING FROM CONTROL SUBJECTS$0
M01 · FY2002 · RR
BLOOD SAMPLING FROM CONTROL SUBJECTS$0
M01 · FY2002 · RR
BLOOD SAMPLING FROM CONTROL SUBJECTS$0
M01 · FY2002 · RR
BLOOD SAMPLING FROM CONTROL SUBJECTS$0
M01 · FY2002 · RR
ISOTOPE STUDY OF PYRUVATE METABOLISM IN LACTIC ACIDEMIA$0
M01 · FY2002 · RR
ISOTOPE STUDY OF PYRUVATE METABOLISM IN LACTIC ACIDEMIA$0
M01 · FY2002 · RR
ISOTOPE STUDY OF PYRUVATE METABOLISM IN LACTIC ACIDEMIA$0
M01 · FY2002 · RR
ISOTOPE STUDY OF PYRUVATE METABOLISM IN LACTIC ACIDEMIA$0
M01 · FY2002 · RR
TOLERANCE EVALUATION OF FRUCTO-OLIGOSACCHARIDES IN FRUCTOSE INTOLERANCE$0
M01 · FY2002 · RR
TOLERANCE EVALUATION OF FRUCTO-OLIGOSACCHARIDES IN FRUCTOSE INTOLERANCE$0
M01 · FY2002 · RR
TOLERANCE EVALUATION OF FRUCTO-OLIGOSACCHARIDES IN FRUCTOSE INTOLERANCE$0
M01 · FY2002 · RR
TOLERANCE EVALUATION OF FRUCTO-OLIGOSACCHARIDES IN FRUCTOSE INTOLERANCE$0
M01 · FY2001 · RR
ISOTOPE STUDY OF PYRUVATE METABOLISM IN LACTIC ACIDEMIA$0
M01 · FY2001 · RR
ISOTOPE STUDY OF PYRUVATE METABOLISM IN LACTIC ACIDEMIA$0
M01 · FY2001 · RR
BLOOD SAMPLING FROM CONTROL SUBJECTS$0
M01 · FY2001 · RR
BLOOD SAMPLING FROM CONTROL SUBJECTS$0
M01 · FY2001 · RR
TOLERANCE EVALUATION OF FRUCTO-OLIGOSACCHARIDES IN FRUCTOSE INTOLERANCE$0
M01 · FY2001 · RR
BLOOD SAMPLING FROM CONTROL SUBJECTS$0
M01 · FY2000 · RR
BLOOD SAMPLING FROM CONTROL SUBJECTS$0
M01 · FY2000 · RR
BLOOD SAMPLING FROM CONTROL SUBJECTS$0
M01 · FY2000 · RR
TOLERANCE EVALUATION OF FRUCTO-OLIGOSACCHARIDES IN FRUCTOSE INTOLERANCE$0
M01 · FY2000 · RR
TOLERANCE EVALUATION OF FRUCTO-OLIGOSACCHARIDES IN FRUCTOSE INTOLERANCE$0
M01 · FY2000 · RR
ISOTOPE STUDY OF PYRUVATE METABOLISM IN LACTIC ACIDEMIA$0
M01 · FY2000 · RR
ISOTOPE STUDY OF PYRUVATE METABOLISM IN LACTIC ACIDEMIA$0
M01 · FY2000 · RR
ISOTOPE STUDY OF PYRUVATE METABOLISM IN LACTIC ACIDEMIA$0
M01 · FY2000 · RR